Fiomi Diagnostics is develops a panel of point-of-care cardiac marker assays.
Business Model:
Revenue: $0
Employees: 0-0
Fiomi Diagnostics was acquired by
Trinity Biotech.
The acquisition happend on 2012-03-01.
Details of the transaction were not public
Address:
City: Uppsala
State: Uppsala Lan
Zip:
Country: Sweden
Fiomi Diagnostics is develops a panel of point-of-care cardiac marker assays. The company’s forecast technology enables picomolar sensitivity for whole-blood in vitro diagnostic immunoassays at the point of care. Its technology is based on a microstructured plastic chip, which provides a highly repeatable flow of fluid in lateral flow assays and an efficient fluorescence detection system providing quantitative test results.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|